Financial Reports Latest Updates Industry Maps Economic Calendar

Verastem, Inc. (VSTM) Annual Reports

Q: Where can I read Verastem, Inc. (VSTM) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Verastem, Inc. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1526119 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$40.1M	$2.1M	+1775.4%
Operating income	$-32.7M	$-43.8M	+25.3%
Net income	$-34.7M	$-25.9M	-33.7%
EPS (diluted)	$-0.35	$-0.62	+43.5%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 40.1 mn Net income -34.7 mn

Show table：Income statement

Item	2011Q1	2011Q1	2011Q2	2011Q3	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	10.0	15.5	1.21	1.67	3.14	9.03	3.62	5.06	4.31	78.7	0.51	1.01	0.5	0	0.55	2.60	0	0	0	—	—	—	—	—	10.0	0	0	—	2.14	11.2	17.5	18.7	40.1
Operating income	-0.78	-1.15	-2.48	-4.05	-6.02	-6.93	-6.90	-10.4	-7.98	-9.08	-10.3	-10.6	-11.4	-13.1	-13.1	-13.4	-14.0	-15.2	-15.5	-15.5	-12.0	-8.43	-8.71	-8.06	-11.8	-13.2	-13.5	-23.1	-18.1	-20.8	-18.2	-21.6	-34.3	-34.7	-38.3	-26.1	-33.3	-26.4	-21.3	15.0	-16.8	-14.1	-15.9	-14.8	-16.5	-17.0	-21.4	-17.7	-16.9	-19.3	-20.3	-21.3	-31.1	-28.1	-18.3	-37.0	-31.6	-44.2	-43.8	-40.7	-41.5	-44.9	-32.7
Net income	-0.78	-1.15	-2.48	-4.05	-6.00	-6.87	-6.82	-10.4	-7.92	-9.04	-10.3	-10.6	-11.3	-13.1	-13.0	-13.3	-13.9	-15.2	-15.4	-15.4	-11.9	-8.29	-8.57	-7.92	-11.7	-13.0	-13.4	-23.1	-18.2	-21.1	-18.4	-21.7	-11.3	-38.1	-42.2	-30.1	-38.8	-38.0	-23.0	13.1	-19.9	-15.0	-16.9	-22.8	-16.5	-17.0	-21.9	-18.1	-16.8	-15.7	-24.3	-20.0	-27.4	-33.9	-8.26	-24.0	-64.5	-52.1	-25.9	-98.5	-32.9	-36.6	-34.7

Balance sheet

Quarterly · In mn (USD)

Total assets 207 mn Total liabilities 157 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011Q1	2011Q1	2011Q2	2011Q3	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	—	47.9	41.6	39.2	47.3	57.1	67.7	58.3	101	102	107	99.6	94.5	95.3	135	133	121	111	101	93.5	87.3	81.3	74.0	59.8	61.2	87.8	66.0	170	159	253	217	192	167	85.0	149	145	189	145	128	115	109	106	113	97.9	109	92.9	119	190	174	144	118	99.7	121	95.0	125	174	154	223	203	176
Total assets	—	—	—	—	59.0	111	106	98.8	92.9	86.2	80.0	132	125	116	107	97.9	98.7	142	136	124	113	103	95.4	89.0	83.6	76.3	61.8	63.1	89.8	68.4	173	183	277	243	219	193	145	208	199	218	154	137	124	112	109	116	100	111	95.0	121	192	176	150	124	106	126	102	132	196	177	246	228	207
Current liabilities	—	—	—	—	3.15	2.94	3.21	3.15	2.40	3.36	5.24	5.71	7.80	6.39	7.87	8.39	9.20	9.46	9.84	10.9	10.1	6.12	5.93	6.22	11.0	13.2	11.1	19.6	17.1	14.8	22.1	53.4	37.1	28.6	31.2	30.5	29.9	25.7	28.8	37.7	17.1	11.8	12.7	13.5	18.6	16.9	20.1	21.9	21.7	22.4	20.8	23.8	26.4	26.7	30.4	37.4	31.0	35.6	50.4	59.7	72.3	66.8	78.1
Total liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	11.3	15.8	13.6	22.1	32.1	29.9	46.0	75.5	153	155	169	171	138	85.2	84.2	88.0	39.1	34.3	35.7	16.2	21.1	43.4	46.5	48.2	47.7	66.7	69.0	71.8	71.2	77.3	65.7	94.2	130	164	160	192	189	146	157
Equity	-0.69	—	—	—	-12.8	108	102	95.6	90.5	82.8	74.7	127	117	109	99.2	88.8	88.8	132	125	112	102	96.0	89.1	82.4	72.3	60.5	48.2	41.0	57.7	38.5	127	108	124	88.5	49.3	21.5	7.17	123	114	130	115	103	88.2	95.7	87.6	72.8	53.9	62.9	47.4	33.0	102	83.2	57.4	25.1	18.9	11.1	-28.9	-32.4	36.1	-15.5	57.2	81.8	50.0

Cash flow

Quarterly · In mn (USD)

Operating -43.9 mn Investing 16.3 mn Financing -1.54 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011Q1	2011Q1	2011Q2	2011Q3	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-0.33	-0.87	-0.16	-4.27	-4.07	-4.89	-5.05	-6.74	-5.92	-6.34	-6.32	-7.10	-6.54	-9.28	-8.72	-9.26	-9.65	-11.7	-12.0	-11.6	-10.2	-10.8	-6.69	-6.02	-5.95	-10.7	-14.5	-11.8	-20.3	-22.4	-10.3	-22.6	-19.2	-38.8	-34.7	-27.9	-37.2	-34.0	-22.6	44.8	-21.7	-19.3	-13.4	-10.8	-9.93	-19.3	-12.7	-15.1	-16.6	-20.3	-19.9	-16.6	-29.7	-28.3	-27.6	-23.8	-25.1	-38.7	-32.7	-36.2	-29.9	-52.1	-43.9
Investing	-0.01	0	-0.47	-0.37	-35.9	-48.2	-4.67	2.11	4.89	25.3	-8.01	-43.4	2.79	4.12	17.9	7.62	13.5	-47.4	8.94	-3.79	15.2	1.10	31.1	3.73	1.03	4.10	14.0	21.3	4.51	4.43	-0.53	-15.5	-127	0.36	46.5	17.6	25.1	32.0	-0.03	-0.01	-79.4	-12.4	2.39	10.0	0.07	19.3	29.3	4.65	13.0	-0.8	14.0	-70.1	12.4	31.0	29.0	0	0	—	—	-8.28	-1.34	-16.0	16.3
Financing	3.92	0	12.1	31.9	19.5	57.6	0	0	0	-0.76	-0.03	59.3	0	-0.49	-0.06	-0.2	9.52	55.4	8.12	0.06	0.05	0	0	0	0	2.39	-0.14	14.2	46.7	0.3	115	0.07	145	0.08	9.69	0.49	-12.7	93.4	12.7	0.14	-36.6	-0.58	0.49	0.17	6.81	25.4	0.71	25.6	0	44.0	91.5	-0.89	-0.45	0.85	-0.4	53.6	0.74	67.4	79.4	17.9	98.6	28.7	-1.54
Cash at period end	3.58	2.72	14.2	41.4	20.9	25.5	15.8	11.1	10.1	28.3	13.9	22.6	18.9	13.2	22.4	20.6	33.9	30.1	35.2	19.8	24.9	15.2	39.6	37.3	32.4	28.2	27.6	51.3	82.2	64.2	169	131	130	91.5	113	103	43.5	135	125	170	67.8	35.5	25.0	24.3	21.3	46.7	64.0	78.2	74.9	97.3	183	95.0	77.9	81.3	83.4	113	88.8	118	164	138	205	166	136

Profitability

Quarterly · %

Operating margin -81.6% Net margin -86.5%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011Q1	2011Q1	2011Q2	2011Q3	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-181.9%	-139.1%	-2831.3%	-2074.8%	-1220.6%	-289.0%	-920.4%	-521.3%	-493.7%	19.1%	-3311.1%	-1402.4%	-3188.8%	-742300.0%	-3029.5%	-654.1%	—	—	—	—	—	—	—	—	-182.8%	—	—	—	-2047.9%	-362.2%	-236.5%	-240.5%	-81.6%
Net margin	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-183.7%	-139.7%	-937.9%	-2280.2%	-1345.5%	-333.7%	-1072.0%	-751.4%	-534.3%	16.7%	-3925.7%	-1494.1%	-3380.4%	-1139300.0%	-3024.0%	-653.4%	—	—	—	—	—	—	—	—	-82.6%	—	—	—	-1213.6%	-876.3%	-187.7%	-196.0%	-86.5%

Returns & leverage

Quarterly · %

ROE -471.2% ROA -100.7% Debt ratio 75.8%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2011Q1	2011Q1	2011Q2	2011Q3	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	-18.0%	-23.2%	-31.4%	-82.3%	-35.9%	-42.4%	-34.0%	-39.6%	-47.1%	-55.2%	-47.1%	-51.8%	-46.0%	-51.5%	-59.6%	-60.5%	-44.7%	-41.2%	-37.6%	-41.7%	-52.6%	-67.0%	-99.2%	-104.3%	-153.2%	-92.3%	-106.8%	-79.6%	-140.9%	-128.6%	-188.6%	-227.0%	-141.0%	-158.7%	-114.5%	-110.6%	-39.7%	-38.2%	-66.2%	-70.2%	-83.4%	-110.0%	-92.7%	-109.4%	-137.2%	-96.3%	-105.2%	-166.8%	-363.3%	-148.6%	-198.3%	-917.4%	—	-606.7%	—	-1480.2%	-786.1%	-471.2%
ROA	—	—	—	—	-23.2%	-17.5%	-22.5%	-30.4%	-42.1%	-34.7%	-40.5%	-32.7%	-37.8%	-44.8%	-51.3%	-44.1%	-47.7%	-43.1%	-47.6%	-54.1%	-54.7%	-41.7%	-38.2%	-34.5%	-37.0%	-46.0%	-58.5%	-80.5%	-78.2%	-104.9%	-68.8%	-64.4%	-39.5%	-57.4%	-57.9%	-64.8%	-70.7%	-66.0%	-62.3%	-42.2%	-45.2%	-25.9%	-24.0%	-45.3%	-54.1%	-57.8%	-69.7%	-65.9%	-72.5%	-61.2%	-51.3%	-53.5%	-71.4%	-86.3%	-60.2%	-61.8%	-104.0%	-116.7%	-110.3%	-159.0%	-120.4%	-107.9%	-100.7%
Debt ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	13.6%	20.7%	22.0%	35.1%	35.8%	43.6%	26.6%	41.2%	55.2%	63.6%	77.4%	88.8%	95.0%	40.9%	42.4%	40.4%	25.3%	25.1%	28.8%	14.5%	19.4%	37.4%	46.3%	43.4%	50.1%	55.2%	36.0%	40.8%	47.5%	62.6%	62.2%	74.5%	128.5%	124.6%	81.6%	108.8%	76.8%	64.1%	75.8%

EPS

Quarterly · US$

EPS US$-0.35

Show table：EPS

Item	2011Q1	2011Q1	2011Q2	2011Q3	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.99	—	—	—	-1.76	-0.41	-0.30	-0.29	-0.37	-0.52	-0.57	-0.41	-0.51	-0.35	-0.14	0.08	-0.12	-0.09	-0.10	-0.13	-0.10	-0.09	-0.12	-0.09	-0.08	-0.08	-1.37	-0.75	-1.00	-1.26	-0.31	-0.60	-1.55	-0.96	-0.62	-1.35	-0.29	-0.46	-0.35

Revenue & profit

Year-to-date · In mn (USD)

Revenue 58.8 mn Net income -71.3 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 207 mn Total liabilities 157 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -96.0 mn Investing 0.24 mn Financing 27.1 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin -132.1% Net margin -121.3%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -471.2% ROA -100.7% Debt ratio 75.8%

EPS

Year-to-date · US$

EPS US$-0.81

Revenue & profit

Annual · In mn (USD)

Revenue 2.60 mn Net income -209 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	—	—	—	—	—	17.5	88.5	2.05	2.60	—	—	—
Operating income	-14.5	-58.2	-37.0	-67.8	-94.8	-132	-49.4	-61.4	-72.9	-92.1	-115	-170
Net income	-14.5	-57.9	-36.4	-67.8	-72.4	-149	-67.7	-71.2	-73.8	-87.4	-131	-209

Balance sheet

Annual · In mn (USD)

Total assets 246 mn Total liabilities 189 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	47.9	111	81.3	87.8	253	85.0	145	106	92.9	144	95.0	223
Total assets	59.0	113	83.6	89.8	277	145	154	109	95.0	150	102	246
Current liabilities	3.15	10.1	11.0	17.1	37.1	29.9	17.1	18.6	21.7	26.4	31.0	72.3
Total liabilities	—	—	11.3	32.1	153	138	39.1	21.1	47.7	71.2	130	189
Equity	-12.8	102	72.3	57.7	124	7.17	115	87.6	47.4	57.4	-28.9	57.2

Cash flow

Annual · In mn (USD)

Operating -138 mn Investing 60.0 mn Financing 263 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-9.70	-45.6	-29.5	-57.3	-74.5	-139	-33.5	-53.5	-63.7	-86.5	-105	-138
Investing	-36.7	-27.1	37.0	44.0	-138	89.6	-47.4	0.09	66.2	-44.5	60.0	—
Financing	67.4	63.6	0	63.2	261	-2.44	69.6	6.89	51.8	134	54.8	263
Cash at period end	20.9	24.9	32.4	82.2	130	43.5	67.8	21.3	74.9	77.9	88.8	205

Profitability

Annual · %

Operating margin -2809.6% Net margin -2843.3%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	—	—	—	—	—	-758.1%	-55.8%	-2991.2%	-2809.6%	—	—	—
Net margin	—	—	—	—	—	-854.8%	-76.5%	-3468.1%	-2843.3%	—	—	—

Returns & leverage

Annual · %

ROE -1480.2% ROA -120.4% Debt ratio 76.8%

Show table：Returns & leverage

Item	2011	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	—	-129.0%	-41.7%	-104.3%	-79.6%	-227.0%	-110.6%	-70.2%	-109.4%	-166.8%	-917.4%	-1480.2%
ROA	-24.5%	-67.2%	-37.0%	-78.2%	-39.5%	-70.7%	-45.2%	-54.1%	-72.5%	-71.4%	-104.0%	-120.4%
Debt ratio	—	—	13.6%	35.8%	55.2%	95.0%	25.3%	19.4%	50.1%	47.5%	128.5%	76.8%

EPS

Annual · US$

EPS US$-3.22

Show table：EPS

Item	2011	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	-1.37	-2.01	-0.53	-0.42	-0.38	-3.20	-3.72	-3.22

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Verastem, Inc. (VSTM) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.